Buscar
Bausch Health Companies Inc
BHCAñadir a la lista de seguimiento
5.465USD
+0.175+3.31%
Horarios del mercado （ET）Cotizaciones retrasadas 15 min
2.04BCap. mercado
PérdidaP/E TTM
Más Datos de Bausch Health Companies Inc Compañía
Bausch Health Companies Inc. is a global, diversified pharmaceutical company. The Salix segment includes sales in the U.S. of GI products. The International segment includes sales of Bausch + Lomb products and Solta Medical aesthetic medical devices, outside the U.S. and Puerto Rico of branded pharmaceutical products, branded generic pharmaceutical products and OTC products. The Solta Medical segment includes global sales of Solta Medical aesthetic medical devices. The Diversified segment includes sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes, dermatology products, generic pharmaceutical products and dentistry products. The Bausch + Lomb segment includes global sales of Bausch + Lomb Vision Care, Surgical and Pharmaceuticals products. Its drug candidate, Larsucosterol binds to and inhibits the activity of DNA methyltransferases, epigenetic enzymes that are elevated and associated with hypermethylation found in AH patients.
Información de Bausch Health Companies Inc
Símbolo de cotizaciónBHC
Nombre de la empresaBausch Health Companies Inc
Fecha de salida a bolsaSep 20, 1994
Director ejecutivoAppio (Thomas J)
Número de empleados20700
Tipo de seguridadOrdinary Share
Fin del año fiscalSep 20
Dirección2150 St. Elzear Blvd. West
CiudadLAVAL
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísCanada
Código postalH7L 4A8
Teléfono18003611448
Sitio Webhttps://www.bauschhealth.com/
Símbolo de cotizaciónBHC
Fecha de salida a bolsaSep 20, 1994
Director ejecutivoAppio (Thomas J)
Ejecutivos de Bausch Health Companies Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Thomas J. Appio
Mr. Thomas J. Appio
Chief Executive Officer, Director
Chief Executive Officer, Director
903.22K
-173.57%
Mr. Jean-Jacques (JJ) Charhon
Mr. Jean-Jacques (JJ) Charhon
Executive Vice President, Chief Financial Officer
Executive Vice President, Chief Financial Officer
440.81K
+54.80%
Ms. Aimee J. Lenar
Ms. Aimee J. Lenar
Executive Vice President, US Pharma
Executive Vice President, US Pharma
164.94K
+84.61%
Dr. Amy B. Wechsler, M.D.
Dr. Amy B. Wechsler, M.D.
Independent Director
Independent Director
107.87K
-0.72%
Mr. Robert N. Power
Mr. Robert N. Power
Independent Director
Independent Director
6.60K
--
Ms. Sandra Leung
Ms. Sandra Leung
Director
Director
5.95K
-38.90%
Ms. Sarah B. Kavanagh
Ms. Sarah B. Kavanagh
Independent Director
Independent Director
--
--
Mr. John A. Paulson ,
Mr. John A. Paulson ,
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
--
--
Dr. Richard C. Mulligan, Ph.D.
Dr. Richard C. Mulligan, Ph.D.
Independent Director
Independent Director
--
--
Ms. Seana Carson
Ms. Seana Carson
Executive Vice President, General Counsel
Executive Vice President, General Counsel
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Thomas J. Appio
Mr. Thomas J. Appio
Chief Executive Officer, Director
Chief Executive Officer, Director
903.22K
-173.57%
Mr. Jean-Jacques (JJ) Charhon
Mr. Jean-Jacques (JJ) Charhon
Executive Vice President, Chief Financial Officer
Executive Vice President, Chief Financial Officer
440.81K
+54.80%
Ms. Aimee J. Lenar
Ms. Aimee J. Lenar
Executive Vice President, US Pharma
Executive Vice President, US Pharma
164.94K
+84.61%
Dr. Amy B. Wechsler, M.D.
Dr. Amy B. Wechsler, M.D.
Independent Director
Independent Director
107.87K
-0.72%
Mr. Robert N. Power
Mr. Robert N. Power
Independent Director
Independent Director
6.60K
--
Ms. Sandra Leung
Ms. Sandra Leung
Director
Director
5.95K
-38.90%
Desglose de ingresos
Divisa: USDActualizado: lun., 6 de abr
Divisa: USDActualizado: lun., 6 de abr
FY2025
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
Pharmaceutical Products
4.75B
46.24%
Device Products
2.44B
23.76%
OTC
2.01B
19.56%
Branded and Other Generic Products
962.00M
9.37%
Other Product Lines
110.00M
1.07%
Por regiónUSD
Nombre
Ganancia
Proporción
United States and Puerto Rico
6.14B
59.79%
Other Foreign Countries
1.15B
11.23%
China (Country)
493.00M
4.80%
Canada
417.00M
4.06%
Poland
382.00M
3.72%
Otro
1.68B
16.39%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Pharmaceutical Products
4.75B
46.24%
Device Products
2.44B
23.76%
OTC
2.01B
19.56%
Branded and Other Generic Products
962.00M
9.37%
Other Product Lines
110.00M
1.07%
Estadísticas de accionistas
Actualizado: dom., 10 de may
Actualizado: dom., 10 de may
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Paulson (John A.)
19.62%
Paulson & Co. Inc.
19.61%
Meruelo (Alex)
9.84%
GoldenTree Asset Management, LP
9.28%
Nomura Securities Co., Ltd.
2.33%
Otro
39.31%
Accionistas
Accionistas
Proporción
Paulson (John A.)
19.62%
Paulson & Co. Inc.
19.61%
Meruelo (Alex)
9.84%
GoldenTree Asset Management, LP
9.28%
Nomura Securities Co., Ltd.
2.33%
Otro
39.31%
Tipos de accionistas
Accionistas
Proporción
Individual Investor
30.54%
Family Office
19.64%
Investment Advisor/Hedge Fund
16.36%
Investment Advisor
9.28%
Hedge Fund
6.87%
Research Firm
4.78%
Bank and Trust
3.82%
Pension Fund
2.84%
Private Equity
1.40%
Otro
4.48%
Participación institucional
Actualizado: mié., 1 de abr
Actualizado: mié., 1 de abr
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2026Q1
510
173.34M
46.41%
-64.50M
2025Q4
488
175.10M
70.29%
+43.88K
2025Q3
506
175.09M
71.73%
-42.59M
2025Q2
513
217.71M
72.26%
-4.52M
2025Q1
526
222.33M
72.55%
-45.74M
2024Q4
547
234.63M
78.06%
-1.57M
2024Q3
606
235.66M
83.60%
-25.41M
2024Q2
682
261.12M
90.70%
-4.43M
2024Q1
745
265.27M
94.42%
-80.93M
2023Q4
778
267.72M
94.93%
+4.99M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Paulson & Co. Inc.
73.26M
19.77%
--
--
Dec 31, 2025
Meruelo (Alex)
36.76M
9.92%
+148.73K
+0.41%
Mar 31, 2025
GoldenTree Asset Management, LP
34.67M
9.35%
-167.70K
-0.48%
Dec 31, 2025
Nomura Securities Co., Ltd.
8.70M
2.35%
-7.01M
-44.62%
Dec 31, 2025
Healthcare Of Ontario Pension Plan
8.45M
2.28%
-4.55M
-34.98%
Dec 31, 2025
MFN Partners Management LP
6.00M
1.62%
--
--
Dec 31, 2025
National Bank of Canada
5.32M
1.43%
-2.41M
-31.17%
Dec 31, 2025
Kohlberg Kravis Roberts & Co. L.P.
5.24M
1.41%
--
--
Dec 31, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
VanEck Pharmaceutical ETF
0.3%
Gotham 1000 Value ETF
0.18%
FlexShares Morningstar Developed Markets ex-US Factor Tilt Index ETF
0.12%
Schwab International Small-Cap Equity ETF
0.09%
iShares Intl Small Cap Equity Factor ETF
0.08%
DFA Dimensional International Small Cap ETF
0.07%
Schwab Fundamental International Equity ETF
0.04%
Invesco RAFI Developed Mkts ex-US ETF
0.03%
DFA Dimensional Intl Sustainability Core 1 ETF
0.01%
iShares Core MSCI International Developed Mkt ETF
0.01%
Ver más
VanEck Pharmaceutical ETF
Proporción0.3%
Gotham 1000 Value ETF
Proporción0.18%
FlexShares Morningstar Developed Markets ex-US Factor Tilt Index ETF
Proporción0.12%
Schwab International Small-Cap Equity ETF
Proporción0.09%
iShares Intl Small Cap Equity Factor ETF
Proporción0.08%
DFA Dimensional International Small Cap ETF
Proporción0.07%
Schwab Fundamental International Equity ETF
Proporción0.04%
Invesco RAFI Developed Mkts ex-US ETF
Proporción0.03%
DFA Dimensional Intl Sustainability Core 1 ETF
Proporción0.01%
iShares Core MSCI International Developed Mkt ETF
Proporción0.01%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
